Skip to main content
SpringerLink
Log in

Bevacizumab

Nasal septal perforation: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Ramiscal JA, Jatoi A.Bevacizumab-induced nasal septal perforation: incidence of symptomatic, confirmed event(s) in colorectal cancer patients. Acta Oncologica 50: 578-81, No. 4, May 2011 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bevacizumab. React. Wkly. 1375, 8 (2011). https://doi.org/10.2165/00128415-201113750-00021

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113750-00021

Keywords

Search

Navigation